Showing results (631-640 of 10,064) with videos related to
Sort By:
Pageof 1,007
Current Pharmaceutical Design|August 22, 2006
Cannabinoids, immune system and cytokine networkP Massi, A Vaccani, D ParolaroCurrent Pharmaceutical Design|March 12, 2009
Metal complexes, their cellular targets and potential for cancer therapyDi Chen, Vesna Milacic, Michael Frezza, et al.Current Pharmaceutical Design|March 12, 2009
Cytokine/Antibody complexes: an emerging class of immunostimulantsSven MostböckCurrent Pharmaceutical Design|March 12, 2009
The metabolic approach in patients with heart failure: effects on left ventricle remodelingW H Wilson TangCurrent Pharmaceutical Design|March 12, 2009
Effects of metabolic approach in diabetic patients with coronary artery diseaseGabriele Fragasso, Anna Salerno, Roberto Spoladore, et al.Current Pharmaceutical Design|March 12, 2009
Renal protective effect of metabolic therapy in patients with coronary artery disease and diabetes: from bench to bed sideRaphael Thuillier, Jean Paul Tillement, Thierry HauetCurrent Pharmaceutical Design|March 12, 2009
Cardiovascular drug development using radiopharmaceuticalsHeikki Ukkonen, Keiichiro Yoshinaga, Jean N DaSilva, et al.Current Pharmaceutical Design|March 12, 2009
Cancer drug development with the help of radiopharmaceuticals: academic experienceSteven M LarsonCurrent Pharmaceutical Design|March 12, 2009
Radiopharmaceuticals for oncology drug development: a pharmaceutical industry perspectivePhilip S Murphy, Mats BergströmCurrent Pharmaceutical Design|March 12, 2009
Defining pharmacokinetics for individual patient dosimetry in routine radiopeptide and radioimmunotherapy of cancer: Australian experienceJ Harvey TurnerPageof 1,007